1. Home
  2. CGBD vs SDGR Comparison

CGBD vs SDGR Comparison

Compare CGBD & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carlyle Secured Lending Inc.

CGBD

Carlyle Secured Lending Inc.

HOLD

Current Price

$10.92

Market Cap

826.2M

Sector

Finance

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$11.98

Market Cap

925.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGBD
SDGR
Founded
2012
1990
Country
United States
United States
Employees
2500
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
826.2M
925.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CGBD
SDGR
Price
$10.92
$11.98
Analyst Decision
Hold
Buy
Analyst Count
8
9
Target Price
$12.92
$21.00
AVG Volume (30 Days)
641.3K
1.3M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
14.42%
N/A
EPS Growth
N/A
45.14
EPS
N/A
N/A
Revenue
N/A
$255,869,000.00
Revenue This Year
$3.74
$0.76
Revenue Next Year
$1.80
$4.60
P/E Ratio
$10.36
N/A
Revenue Growth
N/A
23.29
52 Week Low
$10.64
$10.95
52 Week High
$14.32
$27.63

Technical Indicators

Market Signals
Indicator
CGBD
SDGR
Relative Strength Index (RSI) 36.03 44.75
Support Level $10.68 $11.18
Resistance Level $12.17 $13.36
Average True Range (ATR) 0.31 0.63
MACD -0.11 -0.09
Stochastic Oscillator 4.95 22.31

Price Performance

Historical Comparison
CGBD
SDGR

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: